3D Model: Illustration Of The Vaccine Administration Process And Immune Response Against Helicobacter Pylori Infection. The Vaccine Is Formulated By Mixing Either WtOMVs Or ROMVs With IL-17A Or IFN-γ, Then Combined With The Antigen Candidates UreB And WCV. The Resulting Vaccine Is Administered Intragastrically, Leading To An Immune Response Involving CD4+ T Cells, MLN Cells, And Splenocytes, As Well As The Secretion Of IgA And IgG Antibodies. The Bacterial Load And Urease Activity Are Also Shown As Indicators Of The Immune Response.